ID   NaUCC-1
AC   CVCL_M680
DR   Wikidata; Q54907494
RX   PubMed=1786199;
RX   PubMed=3171272;
RX   PubMed=3819510;
RX   PubMed=8978593;
CC   Population: Japanese.
CC   Characteristics: Established from a xenograft established in a nude mice.
CC   Doubling time: 17.3 hours (Note=In vivo), 20 hours (Note=In vitro) (PubMed=3171272).
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C4646; Gestational choriocarcinoma
DI   ORDO; Orphanet_99926; Gestational choriocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
RX   PubMed=1786199; DOI=10.1007/BF02221328;
RA   Ino K., Goto S., Kosaki A., Nomura S., Asada E., Misawa T.,
RA   Furuhashi Y., Mizutani S., Tomoda Y.;
RT   "Growth inhibitory effect of bestatin on choriocarcinoma cell lines in
RT   vitro.";
RL   Biotherapy 3:351-357(1991).
//
RX   PubMed=3171272;
RA   Sugiura M., Goto S., Saito M., Kato S., Hattori S., Tomoda Y.;
RT   "Establishment and characterization of three new human gestational
RT   choriocarcinoma cell lines.";
RL   Nihon Sanka Fujinka Gakkai Zasshi 40:1447-1454(1988).
//
RX   PubMed=3819510;
RA   Okayama Y., Goto S., Fan C., Ueda S., Tomoda Y.;
RT   "The study of drug sensitivity on newly established three
RT   choriocarcinoma cell lines.";
RL   Nihon Sanka Fujinka Gakkai Zasshi 39:17-23(1987).
//
RX   PubMed=8978593; DOI=10.1159/000227661;
RA   Wakahara Y., Nawa A., Okamoto T., Hayakawa A., Kikkawa F.,
RA   Suganama N., Wakahara F., Tomoda Y.;
RT   "Combination effect of anti-Fas antibody and chemotherapeutic drugs in
RT   ovarian cancer cells in vitro.";
RL   Oncology 54:48-54(1997).
//